Abstract
Neurological diseases are caused by defects in the brain, spinal cord, or nervous system. Excluding animal models, ex vivo brain tissues and brain organoids have been used for modeling neurological diseases. In addition, the blood–brain barrier (BBB) is a selective semipermeable membrane that separates the peripheral blood from the neural tissue. Thus, it regulates homeostasis of the brain and selectively delivers substances essential for brain function. The property of the BBB can often be a double-edged sword by impeding the penetration of therapeutic drugs for brain diseases. Dysregulation of the BBB can lead to various neurological diseases. To date, significant efforts have been made to develop human brain organoids and BBB models with pluripotent stem cells for mimicking neurological diseases. Since human ex vivo brain tissues are difficult to obtain from a patient directly, induced pluripotent stem cells (iPSCs) generated by genetic reprogramming of adult somatic cells have been differentiated into specific neural cell types or brain organoids. Conventionally, major brain cell types including neurons, oligodendrocytes, and astrocytes have been generated from iPSCs in two-dimensional (2D) monolayer culture plates, whereas brain organoids have been differentiated in three-dimensional (3D) culture systems. Region-specific brain organoids become an important tool to study biological mechanisms of neurological disorders. Nonetheless, brain organoids generated in static conditions show several challenges in culture, which include diffusion limitation of nutrients and oxygen and removal of metabolic waste. To resolve these issues, microfluidic chip systems have been adopted for brain organoid culture and facilitate disease modeling and precision medicine. In this short review, we summarize recent advances in brain organoid culture with iPSCs and brain organoid-on-a-chip.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13206-022-00075-y/MediaObjects/13206_2022_75_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13206-022-00075-y/MediaObjects/13206_2022_75_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13206-022-00075-y/MediaObjects/13206_2022_75_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13206-022-00075-y/MediaObjects/13206_2022_75_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13206-022-00075-y/MediaObjects/13206_2022_75_Fig5_HTML.png)
Similar content being viewed by others
References
Heffernan, A.L., Hare, D.J.: Tracing environmental exposure from neurodevelopment to neurodegeneration. Trends Neurosci. 41, 496–501 (2018)
Pacitti, D., Privolizzi, R., Bax, B.E.: Organs to cells and cells to organoids: the evolution of in vitro central nervous system modelling. Front Cell Neurosci. 13, 129 (2019)
Lee, S.J., Lee, H.A.: Trends in the development of human stem cell-based non-animal drug testing models. Korean J Physiol Pharmacol. 24, 441–452 (2020)
Akhtar, A.: The flaws and human harms of animal experimentation. Camb Q Healthc Ethics. 24, 407–419 (2015)
Takahashi, K., et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007)
Loh, Y.H., et al.: Generation of induced pluripotent stem cells from human blood. Blood 113, 5476–5479 (2009)
Choi, N.Y., et al.: Novel imprinted single CpG sites found by global DNA methylation analysis in human parthenogenetic induced pluripotent stem cells. Epigenetics 13, 343–351 (2018)
Chandrasekaran, A., et al.: Astrocyte differentiation of human pluripotent stem cells: new tools for neurological disorder research. Front Cell Neurosci. 10, 215 (2016)
Biswas, S., et al.: Development of glial restricted human neural stem cells for oligodendrocyte differentiation in vitro and in vivo. Sci Rep. 9, 9013 (2019)
Douvaras, P., Fossati, V.: Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells. Nat Protoc. 10, 1143–1154 (2015)
Hu, B.Y., et al.: Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA. 107, 4335–4340 (2010)
Bianchi, F., et al.: Rapid and efficient differentiation of functional motor neurons from human iPSC for neural injury modelling. Stem Cell Res. 32, 126–134 (2018)
Cheng, S.H., et al.: 4q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4. Blood. 109, 2089–2099 (2007)
Kapalczynska, M., et al.: 2D and 3D cell cultures—a comparison of different types of cancer cell cultures. Arch Med Sci. 14, 910–919 (2018)
Ravi, M., et al.: 3D cell culture systems: advantages and applications. J Cell Physiol. 230, 16–26 (2015)
Duval, K., et al.: Modeling physiological events in 2D vs. 3D cell culture. Physiology (Bethesda). 32, 266–277 (2017)
Kitaeva, K.V., Rutland, C.S., Rizvanov, A.A., Solovyeva, V.V.: Cell culture based in vitro test systems for anticancer drug screening. Front Bioeng Biotechnol. 8, 322 (2020)
Langhans, S.A.: Three-dimensional in vitro cell culture models in drug discovery and drug repositioning. Front Pharmacol. 9, 6 (2018)
Kim, J., Koo, B.K., Knoblich, J.A.: Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 21, 571–584 (2020)
Velasco, V., Shariati, S.A., Esfandyarpour, R.: Microtechnology-based methods for organoid models. Microsyst Nanoeng. 6, 76 (2020)
Torok, E., et al.: Optimization of hepatocyte spheroid formation for hepatic tissue engineering on three-dimensional biodegradable polymer within a flow bioreactor prior to implantation. Cells Tissues Organs 169, 34–41 (2001)
Xia, Y., Izpisua Belmonte, J.C.: Design approaches for generating organ constructs. Cell Stem Cell. 24, 877–894 (2019)
Noh, Y.K., et al.: Polymer mesh scaffold combined with cell-derived ECM for osteogenesis of human mesenchymal stem cells. Biomater Res. 20, 6 (2016)
Tibbitt, M.W., Anseth, K.S.: Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng. 103, 655–663 (2009)
Gurkan, U.A., et al.: Emerging technologies for assembly of microscale hydrogels. Adv Healthc Mater. 1, 149–158 (2012)
Gattazzo, F., Urciuolo, A., Bonaldo, P.: Extracellular matrix: a dynamic microenvironment for stem cell niche. Biochim Biophys Acta. 1840, 2506–2519 (2014)
Frantz, C., Stewart, K.M., Weaver, V.M.: The extracellular matrix at a glance. J Cell Sci. 123, 4195–4200 (2010)
Lancaster, M.A., et al.: Cerebral organoids model human brain development and microcephaly. Nature 501, 373–379 (2013)
Eiraku, M., et al.: Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3, 519–532 (2008)
Qian, X., et al.: Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165, 1238–1254 (2016)
Kadoshima, T., et al.: Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell-derived neocortex. Proc Natl Acad Sci USA. 110, 20284–20289 (2013)
Xiang, Y., et al.: Fusion of regionally specified hPSC-derived organoids models human brain development and interneuron migration. Cell Stem Cell. 21, 383-398 e387 (2017)
Jo, J., et al.: Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons. Cell Stem Cell 19, 248–257 (2016)
Xiang, Y., et al.: hESC-derived thalamic organoids form reciprocal projections when fused with cortical organoids. Cell Stem Cell. 24, 487-497 e487 (2019)
Park, D., Lim, J., Park, J.Y., Lee, S.H.: Concise review: stem cell microenvironment on a chip: current technologies for tissue engineering and stem cell biology. Stem Cells Transl Med. 4, 1352–1368 (2015)
Saliba, J., et al.: Development of microplatforms to mimic the in vivo architecture of CNS and PNS physiology and their diseases. Genes (Basel) (2018). https://doi.org/10.3390/genes9060285
Karzbrun, E., et al.: Human brain organoids on a chip reveal the physics of folding. Nat Phys. 14, 515–522 (2018)
Cho, A.N., et al.: Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids. Nat Commun. 12, 4730 (2021)
Wang, Y., Wang, L., Zhu, Y., Qin, J.: Human brain organoid-on-a-chip to model prenatal nicotine exposure. Lab Chip. 18, 851–860 (2018)
Cui, K., et al.: Neurodevelopmental impairment induced by prenatal valproic acid exposure shown with the human cortical organoid-on-a-chip model. Microsyst Nanoeng. 6, 49 (2020)
Bagley, J.A., et al.: Fused cerebral organoids model interactions between brain regions. Nat Methods. 14, 743–751 (2017)
Chukwurah, E., Osmundsen, A., Davis, S.W., Lizarraga, S.B.: All together now: modeling the interaction of neural with non-neural systems using organoid models. Front Neurosci. 13, 582 (2019)
Reiner, O., Sapir, T., Parichha, A.: Using multi-organ culture systems to study Parkinson’s disease. Mol Psychiatry. 26, 725–735 (2021)
Au, S.H., et al.: Hepatic organoids for microfluidic drug screening. Lab Chip. 14, 3290–3299 (2014)
Marsano, A., et al.: Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues. Lab Chip. 16, 599–610 (2016)
Huh, D., et al.: Reconstituting organ-level lung functions on a chip. Science 328, 1662–1668 (2010)
Lee, H.N., et al.: Effect of biochemical and biomechanical factors on vascularization of kidney organoid-on-a-chip. Nano Converg. 8, 35 (2021)
Jin, Y., et al.: Vascularized liver organoids generated using induced hepatic tissue and dynamic liver-specific microenvironment as a drug testing platform. Adv Funct Mater. (2018). https://doi.org/10.1002/adfm.201801954
Skardal, A., et al.: Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform. Sci Rep. 7, 8837 (2017)
Mark, D., et al.: Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications. Chem Soc Rev. 39, 1153–1182 (2010)
Wu, Q., et al.: Organ-on-a-chip: recent breakthroughs and future prospects. Biomed Eng Online. 19, 9 (2020)
Whitesides, G.M.: The origins and the future of microfluidics. Nature 442, 368–373 (2006)
Bhatia, S.N., Ingber, D.E.: Microfluidic organs-on-chips. Nat Biotechnol. 32, 760–772 (2014)
Vatine, G.D., et al.: Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications. Cell Stem Cell. 24, 995-1005 e1006 (2019)
Alahmari, A.: Blood-brain barrier overview: structural and functional correlation. Neural Plast. 2021, 6564585 (2021)
Helm, F., Fricker, G.: Liposomal conjugates for drug delivery to the central nervous system. Pharmaceutics. 7, 27–42 (2015)
Ahn, S.I., et al.: Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms. Nat Commun. 11, 175 (2020)
Abbott, N.J., et al.: Structure and function of the blood-brain barrier. Neurobiol Dis. 37, 13–25 (2010)
Palmiotti, C.A., et al.: In vitro cerebrovascular modeling in the 21st century: current and prospective technologies. Pharm Res. 31, 3229–3250 (2014)
Cucullo, L., et al.: The role of shear stress in Blood-Brain Barrier endothelial physiology. BMC Neurosci. 12, 40 (2011)
Brown, J.A., et al.: Recreating blood-brain barrier physiology and structure on chip: a novel neurovascular microfluidic bioreactor. Biomicrofluidics 9, 054124 (2015)
Achyuta, A.K., et al.: A modular approach to create a neurovascular unit-on-a-chip. Lab Chip. 13, 542–553 (2013)
Jeong, S., et al.: A three-dimensional arrayed microfluidic blood-brain barrier model with integrated electrical sensor array. IEEE Trans Biomed Eng. 65, 431–439 (2018)
Jeong, S., et al.: Numerical approach-based simulation to predict cerebrovascular shear stress in a blood-brain barrier organ-on-a-chip. Biosens Bioelectron. 183, 113197 (2021)
Aday, S., et al.: Stem cell-based human blood-brain barrier models for drug discovery and delivery. Trends Biotechnol. 34, 382–393 (2016)
Delsing, L., et al.: Models of the blood-brain barrier using iPSC-derived cells. Mol Cell Neurosci. 107, 103533 (2020)
Delsing, L., et al.: Barrier properties and transcriptome expression in human iPSC-derived models of the blood-brain barrier. Stem Cells. 36, 1816–1827 (2018)
Qian, T., et al.: Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells. Sci Adv. 3, e1701679 (2017)
Linville, R.M., et al.: Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior. Biomaterials 190–191, 24–37 (2019)
Lee, C.T., et al. CYP3A5 mediates effects of cocaine on human neocorticogenesis: studies using an in vitro 3D self-organized hPSC model with a single cortex-like unit. Neuropsychopharmacology 42, 774–784 (2017)
Pasca, A.M., et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods 12, 671–678 (2015)
Lancaster, M.A., Knoblich, J.A. Generation of cerebral organoids from human pluripotent stem cells. Nat. Protoc. 9, 2329–2340 (2014)
Acknowledgements
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT). (No. NRF-2021R1I1A3061265).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
There are no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Choi, N.Y., Lee, MY. & Jeong, S. Recent Advances in 3D-Cultured Brain Tissue Models Derived from Human iPSCs. BioChip J 16, 246–254 (2022). https://doi.org/10.1007/s13206-022-00075-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13206-022-00075-y